Type I glutaric aciduria, part 2: A model of acute striatal necrosis

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 121 C, Issue 1, 2003, Pages 53-70

  Strauss, Kevin A ^a   Morton, D Holmes ^a  

^a CLINIC FOR SPECIAL CHILDREN   (United States)

Author keywords

Acute striatal necrosis; Amish; Glutaric aciduria

Indexed keywords

3 NITROPROPIONIC ACID; 3-NITROPROPIONIC ACID; GLUTARYL COENZYME A DEHYDROGENASE; NEUROTOXIN; OXIDOREDUCTASE; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

BIOLOGICAL MODEL; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN NECROSIS; CLINICAL FEATURE; CORPUS STRIATUM; GENETICS; GLUTARIC ACIDURIA TYPE 1; GRAY MATTER; HUMAN; INBORN ERROR OF METABOLISM; METABOLIC DISORDER; METABOLIC ENCEPHALOPATHY; METABOLISM; MODEL; NECROSIS; NEUROLOGICAL COMPLICATION; NEUROPATHOLOGY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DEFICIENCY; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUTAMEN; REVIEW; STROKE;

EID: 0042508735     PISSN: 15524868     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.c.20008     Document Type: Review

References (202)

1. Abbott NJ. 2000. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 20:131-147.
2. Albensi BC, Schweizer MP, Rarick TM, Filloux F. 1999. Unilateral hypoxic-ischemic injury in the neonatal rat brain evaluated by in vivo MRI. Invest Radiol 34:249-261.
3. Allan SM, Harrison DC, Read S, Collins B, Parsons AA, Philpott K, Rothwell NJ. 2001. Selective increases in cytokine expression in the rat brain in response to striatal injection of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and interleukin-1. Brain Res Mol Brain Res 93:180-189.
4. Alves PM, Fonseca LL, Peixoto CC, Almeida AC, Carrondo MJ, Santos H. 2000. NMR studies on energy metabolism of immobilized primary neurons and astrocytes during hypoxia, ischemia and hypoglycemia. NMR Biomed 13:438-448.
5. Arenillas JF, Rovira A, Molina CA, Grive E, Montaner J, Alvarez-Sabin J. 2002. Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke 33:2197-2205.
6. Armentero MT, Fancellu R, Nappi G, Blandini F. 2002. Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat. Exp Neurol 178:301-305.
7. Aschner M. 2000. Neuron-astrocyte interactions: implications for cellular energetics and antioxidant levels. Neurotoxicology 21: 1101-1108.
8. Auer RN, Siesjo BK. 1988. Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 24:699-707.
9. Barros LF, Hermosilla T, Castro J. 2001. Necrotic volume increase and the early physiology of necrosis. Comp Biochem Physiol A Mol Integr Physiol 130:401-409.
10. Ben-Ami T, Yousefzadeh D, Backus M, Reichman B, Kessler A, Hammerman-Rozenberg C. 1990. Lenticulostriate vasculopathy in infants with infections of the central nervous system sonographic and Doppler findings. Pediatr Radiol 20:575-579.
11. Ben-Menachem G, Rottem S, Tarshis M, Barash V, Brenner T. 1998. Mycoplasma fermentans glycolipid triggers inflammatory responses in rat astrocytes. Brain Res 803: 34-38.
12. Berger JR, Nath A, Greenberg RN, Andersen AH, Greene RA, Bognar A, Avison MJ. 2000. Cerebrovascular changes in the basal gangli with HIV dementia. Neurology 54: 921-926.
13. Berry MM, Standring SM, Bannister LH. 1999. Basal nuclei. In: Bannister LH, Berry MM, Collins P, Dyson M, Dussek JE, Ferguson MWJ, editors. Gray's anatomy, 38th edition, New York: Churchill Livingstone. p 1186-1202.
14. Bhattacharjee AK, Nagashima T, Kondoh T, Tamaki N. 2001. Quantification of early blood-brain barrier disruption by in situ brain perfusion technique. Brain Res Brain Res Protoc 8:126-131.
15. Binienda ZK, Ali SF. 2001b. Neuroprotective role of L-carnitine in the 3-nitropropionic acid induced neurotoxicity. Toxicol Lett 125: 67-73.
16. Binienda ZK, Sadovova NV, Rountree RL, Scallet AC, Ali SF. 2001a. Effect of L-carnitine pretreatment on 3-nitropropionic acid-induced inhibition of rat brain succinate dehydrogenase activity. Ann NY Acad Sci 939:359-365.
17. Blum D, Gall D, Cuvelier L, Schiffmann SN. 2001. Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat. Neuroreport 12:1769-1772.
18. Borlongan CV, Yamamoto M, Takei N, Kumazaki M, Ungsuparkorn C, Hida H, Sanberg PR, Nishino H. 2000. Glial cell survival is enhanced during melatonin-induced neuro-protection against cerebral ischemia. FASEB J 14:1307-1317.
19. Brand A, Richter-Landsberg C, Leibfritz D. 1993. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289-298.
20. Brand A, Leibfritz D, Richter-Landsberg C. 1999. Oxidative stress-induced metabolic alterations in rat brain astrocytes studied by multinuclear NMR spectroscopy. J Neurosci Res 58:576-585.
21. Brandel JR, Vidailhet M, Noseda G, Harpey JP, Agid Y. 1996. Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosis. Mov Disord 11:333-336.
22. Brouillet E, Guyot MC, Mittoux V, Altairac S, Conde F, Palfi S, Hantraye P. 1998. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794-805.
23. Brown RE, Stevens DR, Haas HL. 2001. The physiology of brain histamine. Prog Neurobiol 63:637-672.
24. Brustovetsky N, Brustovetsky T, Dubinsky JM. 2001. On the mechanisms of neuroprotection by creatine and phosphocreatine. J Neurochem 76:425-434.
25. Buisson A, Callebert J, Mathieu E, Plotkine M, Boulu RG. 1992. Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. J Neurochem 59:1153-1157.
26. Busquets C, Merinero B, Christensen E, Gelpi JL, Campistol J, Pineda M, Fernandez-Alvarez E, Prats JM, Sans A, Arteaga R, Marti M, Campos J, Martinez-Pardo M, Martinez-Bermejo A, Ruiz-Falco ML, Vaquerizo J, Orozco M, Ugarte M, Coll MJ, Ribes A. 2000. Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 48:315-322.
27. Calabresi P, Gubellini P, Picconi B, Centonze D, Pisani A, Bonsi P, Greengard P, Hipskind RA, Borrelli E, Bernardi G. 2001. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci 21:5110-5120.
28. Calogero AE, Sternberg EM, Bagdy G, Smith C, Bernardini R, Aksentijevich S, Wilder RL, Gold PW, Chrousos GP. 1992. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 55:600-608.
29. Caparros-Lefebvre D, Destee A, Petit H. 1997. Late onset familial dystonia: could mitochondrial deficits induce a diffuse lesioning process of the whole basal ganglia system? J Neurol Neurosurg Psychiatry 63:196-203.
30. Chakrapani A, Sivakuma P, McKiernan PJ, Leonard JV. 2002. Metabolic stroke in methylmalonic acidemia five years after liver transplantation. J Pediatr 140:261-263.
31. Chance B, Leigh JS Jr, Kent J, McCully K. 1986. Metabolic control principles and 31P NMR. Fed Proc 45:2915-2920.
32. Cherry SR, Phelps ME. 1996. Imaging brain function with positron emission tomography. In: Mazziota JC, Toga AW, editors. Brain mapping: the methods. New York: Academic Press. p 191-221.
33. Chugani HT, Phelps ME. 1986. Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science 231:840-846.
34. Chyi T, Chang C. 1999. Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging. Neuroscience 92:1035-1041.
35. Coley BD, Rusin JA, Boue DR. 2000. Importance of hypoxic/ischemic conditions in the development of cerebral lenticulostriate vasculopathy. Pediatr Radiol 30:846-855.
36. Crumrine PC, LaManna JC. 1991. Regional cerebral metabolites, blood flow, plasma volume, and mean transit time in total cerebral ischemia in the rat. J Cereb Blood Flow Metab 11:272-282.
37. Dale RC, Church AJ, Benton S, Surtees RA, Lees A, Thompson EJ, Giovannoni G, Neville BG. 2002. Post-streptococcal autoimmune dystonia with isolated bilateral striatal necrosis. Dev Med Child Neurol 44:485-489.
38. Dautry C, Conde F, Brouillet E, Mittoux V, Beal MF, Bloch G, Hantraye P. 1999. Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid. Neurobiol Dis 6: 259-268.
39. de Mello CF, Kolker S, Ahlemeyer B, de Souza FR, Fighera MR, Mayatepek E, Krieglstein J, Hoffmann GF, Wajner M. 2001. Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res 916:70-75.
40. de Vries LS, Groenendaal F, Eken P, van Haastert IC, Rademaker KJ, Meiners LC. 1997. Infarcts in the vascular distribution of the middle cerebral artery in preterm and full-term infants. Neuropediatrics 28:88-96.
41. del Zoppo GJ, Hallenbeck JM. 2000. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 98:73-81.
42. Delbarre B, Delbarre G, Rochat C, Calinon F. 1995. Effect of piribedil, a D-2 dopaminergic agonist, on dopamine, amino acids, and free radicals in gerbil brain after cerebral ischemia. Mol Chem Neuropathol 26: 43-52.
43. Deshpande SB, Fukuda A, Nishino H. 1997. 3-Nitropropionic acid increases the intracellular Ca2+ in cultured astrocytes by reverse operation of the Na+-Ca2+ exchanger. Exp Neurol 145:38-45.
44. DiMonte DA, Tokar I, Langston JW. 1999. Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures. Toxicol Appl Pharmacol 158:296-302.
45. Donzelli R, Marinkovic S, Brigante L, de Divitiis O, Nikodijevic I, Schonauer C, Maiuri F. 1998. Territories of the perforating (lenticulostriate) branches of the middle cerebral artery. Surg Radiol Anat 20:393-398.
46. Duncan JS. 2000. The epilepsies. In: Mazziotta JC, Toga AW, Frackowiak RSJ, editors. Brain mapping: the disorders. San Diego: Academic Press. p 317-356.
47. Dux E, Joo E 1982. Effects of histamine on brain capillaries: fine structural and immunohistochemical studies after intracarotid infusion. Exp Brain Res 47:252-258.
48. Dux E, Temesvari P, Szerdahelyi P, Nagy A, Kovacs J, Joo F. 1987. Protective effect of antihistamines on cerebral oedema induced by experimental pneumothorax in newborn piglets. Neuroscience 22:317-321.
49. Dux E, Fastbom J, Ungerstedt U, Rudolphi K, Fredholm BB. 1990. Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res 516:248-256.
50. Edelman GM. 1987. Neural Darwinism. New York: Basic Books. p 73-104.
51. Emerson M, Paul W, Page CP. 1999. Regulation of platelet function by catecholamines in the cerebral vasculature of the rabbit. Br J Pharmacol 127:1652-1656.
52. Esposito P, Gheorghe D, Kandere K, Pang X, Connolly R, Jacobson S, Theoharides TC. 2001. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 888:117-127.
53. Fernagut PO, Diguet E, Jaber M, Bioulac B, Tison F. 2002. Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage. Eur J Neurosci 15:2053-2056.
54. Fiebach JB, Schellinger PD, Jansen O, Meyer M, Wilde P, Bender J, Schramm P, Juttler E, Oehler J, Hartmann M, Hahnel S, Knauth M, Hacke W, Sartor K. 2002. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 33:2206-2210.
55. Flacke S, Urbach H, Block W, Traber F, Murtz P, Keller E, Hartmann A, Schild HH. 2002. Perfusion and molecular diffusion-weighted MR imaging of the brain: in vivo assessment of tissue alteration in cerebral ischemia. Amino Acids 23:309-316.
56. Flott-Rahmel B, Falter C, Schluff P, Fingerhut R, Christensen E, Jakobs C, Musshoff U, Fautek JD, Deufel T, Ludolph A, Ullrich K. 1997. Nerve cell lesions caused by 3-hydroxyglutaric acid: a possible mechanism for neurodegeneration in glutaric acidaemia I. J Inherit Metab Dis 20:387-390.
57. Fontaine MA, Geddes JW, Banks A, Butterfield DA. 2000. Effect of exogenous and endogenous antioxidants on 3-nitropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington's disease. J Neurochem 75:1709-1715.
58. Fukuda A, Deshpande SB, Shimano Y, Nishino H. 1998. Astrocytes are more vulnerable than neurons to cellular Ca2+ overload induced by a mitochondrial toxin, 3-nitropropionic acid. Neuroscience 87:497-507.
59. Gabella G. 1999. Carotid system of arteries. In: Bannister LH, Berry MM, Collins P, Dyson M, Dussek JE, Ferguson MWJ, editors. Gray's anatomy, 38th edition. New York: Churchill Livingstone. p 1513-1529.
60. Garcia JH, Liu KF, Yoshida Y, Chen S, Lian J. 1994. Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am J Pathol 145:728-740.
61. Ge H, Wen Y, Yang G, Betz AL. 2000. Increased expression of intercellular adhesion molecule-1 in mouse focal cerebral ischemia model. Chin Med J (Engl) 113:75-79.
62. Ghika JA, Bogousslavsky J, Regli F. 1990. Deep perforators from the carotid system. Template of the vascular territories. Arch Neurol 47:1097-1100.
63. Ghika J, Bogousslavsky J, Regli F. 1991. Infarcts in the territory of lenticulostriate branches from the middle cerebral artery. Etiological factors and clinical features in 65 cases. Schweiz Arch Neurol Psychiatr 142: 5-18.
64. Goodman SI, Frerman FE. 2001. Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, editors. The metabolic and molecular bases of inherited disease, 8th edition. New York: McGraw-Hill. p 2195-2204.
65. Greengard P. 2001. The neurobiology of slow synaptic transmission. Science 2:1024-1030.
66. Gyulai L, Schnall M, McLaughlin AC, Leigh JS Jr, Chance B. 1987. Simultaneous 31P- and 1H-nuclear magnetic resonance studies of hypoxia and ischemia in the cat brain. J Cereb Blood Flow Metab 7:543-551.
67. Hamilton BF, Gould DH. 1987a. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol (Berl) 72:286-297.
68. Hamilton BF, Gould DH. 1987b. Correlation of morphologic brain lesions with physiologic alterations and blood-brain barrier impairment in 3-nitropropionic acid toxicity in rats. Acta Neuropathol (Berl) 74:67-74.
69. Hamilton RL, Haas RH, Nyhan WL, Powell HC, Grafe MR. 1995. Neuropathology of propionic acidemia: a report of two patients with basal ganglia lesions. J Child Neurol 10:25-30.
70. Han J, Cheng FC, Yang Z, Dryhurst G. 1999. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease. J Neurochem 73:1683-1695.
71. Harris NR, Rumbaut RE. 2001. Age-related responses of the microcirculation to ischemia-reperfusion and inflammation. Pathophysiology 8:1-10.
72. Hastings TG, Lewis DA, Zigmond MJ. 1996. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA 93:1956-1961.
73. Hathaway CA, Appleyard CB, Percy WH, Williams JL. 1999. Experimental colitis increases blood-brain barrier permeability in rabbits. Am J Physiol 276(Pt 1):G1174-G1180.
74. Hathaway CA, Percy WH, Williams JL. 2000. Effects of free radicals and leukocytes on increases in blood-brain barrier permeability during colitis. Dig Dis Sci 45:967-975.
75. Henry PG, Lebon V, Vaufrey F, Brouillet E, Hantraye P, Bloch G. 2002. Decreased TCA cycle rate in the rat brain after acute 3-NP treatment measured by in vivo 1H-[13C] NMR spectroscopy. J Neurochem 82:857-866.
76. Hertz L, Yu AC, Kala G, Schousboe A. 2000. Neuronal-astrocytic and cytosolic-mitochondrial metabolite trafficking during brain activation, hyperammonemia, and energy deprivation. Neurochem Int 37: 83-102.
77. Hochachka PW, Guppy M. 1987. Metabolic arrest and the control of biological time. Cambridge, MA: Harvard University p 10-35.
78. Hooper DC, Kean RB, Scott GS, Spitsin SV, Mikheeva T, Morimoto K, Bette M, Rohrenbeck AM, Dietzschold B, Weihe E. 2001. The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol 167:3470-3477.
79. Husain M, Khanna VK, Roy A, Tandon R, Pradeep S, Set PK. 2001. Platelet dopamine receptors and oxidative stress parameters as markers of manganese toxicity. Hum Exp Toxicol 20:631-636.
80. Jabaudon D, Scanziani M, Gahwiler BH, Gerber U. 2000. Acute decrease in net glutamate uptake during energy deprivation. Proc Natl Acad Sci USA 97:5610-5615.
81. Jenkins BG, Brouillet E, Chen YC, Storey E, Schulz JB, Kirschner P, Beal MF, Rosen BR. 1996. Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging. J Cereb Blood Flow Metab 16:450-461.
82. Johkura K, Nishiyama T, Kuroiwa Y. 2002. Bilateral basal ganglia infarctions in a patient with Streptococcus pneumoniae meningitis. Eur Neurol 48:123-124.
83. Johnson D, Yasui D, Seeldrayers P. 1991. An analysis of mast cell frequency in the rodent nervous system: numbers vary between different strains and can be reconstituted in mast cell-deficient mice. J Neuropathol Exp Neurol 50:227-234.
84. Johnson BA, Devous MD Sr, Ruiz P, Ait-Daoud N. 2001. Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists. Am J Psychiatry 108:1191-1198.
85. Johnston MV. 1993. Cellular alterations associated with perinatal asphyxia. Clin Invest Med 16:122-132.
86. Johnston MJ, Trescher WH, Ishida A, Nakjima W. 2001. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatric Res 49:735-741.
87. Kavelaars A, Heijnen CJ, Ellenbroek B, van Loveren H, Cools A. 1997. Apomorphine-susceptible and apomorphine-unsusceptible Wistar rats differ in their susceptibility to inflammatory and infectious diseases: a study on rats with group-specific diferences in structure and reactivity of hypothalamic-pituitary-adrenal axis. J Neurosci 17:2580-2584.
88. Kay L, Nicolay K, Wieringa B, Saks V, Wallimann T. 2000. Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in oxidative muscle cells in situ. J Biol Chem 275:6937-6944.
89. Kempski O, Behmanesh S. 1997. Endothelial cell swelling and brain perfusion. J Trauma 42 (Suppl 5):38S-40S.
90. Kimelberg HK, Sankar P, O'Connor BR, Jalonen T, Goderie SK. 1992. Functional consequences of astrocyte swelling. Prog Brain Res 94:57-68.
91. Koedel U, Bayerlein I, Paul R, Sporer B, Pfister HW. 2000. Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental Pneumococcal meningitis. J Infect Dis 182:1437-1445.
92. Koeller DM, DiGiulio KA, Angeloni SV, Dowler LL, Frerman FE, White RA, Goodman SI. 1995. Cloning, structure, and chromosome localization of the mouse glutaryl-CoA dehydrogenase gene. Genomics 8:508-512.
93. Koeller DM, Woontner M, Crnic LS, Kleinschmidt-DeMasters B, Stephens J, Hunt EL, Goodman SI. 2002. Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet 11:347-357.
94. Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF. 1999. 3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J Inherit Metab Dis 22:259-262.
95. Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GE 2000a. Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase deficiency. Pediatr Res 47(Pt 1):495-503.
96. Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF. 2000b. Evaluation of trigger factors of acute encephalopathy in glutaric aciduria type I: fever and tumour necrosis factor-alpha. J Inherit Metab Dis 23:359-362.
97. Kolker S, Ramaekers VT, Zschocke J, Hoffmann GF. 2001a. Acute encephalopathy despite early therapy in a patient with homozygsity for E365K in the glutaryl-coenzyme A dehydrogenase gene. J Pediatr 138:277-279.
98. Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GE 2001b. Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 50: 76-82.
99. Kolker S, Ahlemeyer B, Huhne R, Mayatepek E, Krieglstein J, Hoffmann GF. 2001c. Potentiation of 3-hydroxyglutarate neurotoxicity following induction of astrocytic iNOS in neonatal rat hippocampal cultures. Eur J Neurosci 13:2115-2122.
100. Komatsumoto S, Nioka S, Greenberg JH, Yoshizaki K, Subramanian VH, Chance B, Reivich M. 1987. Cerebral energy metabolism measured in vivo by 31P-NMR in middle cerebral artery occlusion in the cat - relation to severity of stroke. J Cereb Blood Flow Metab 7:557-562.
101. Komiyama M, Yasui T, Tamura K, Nagata Y, Fu Y, Yagura H. 1995. Simultaneous bleeding from multiple lenticulostriate arteries in hypertensive intracerebral haemorrhage. Neuroradiology 37:129-130.
102. Kondoh T, Lee SH, Low WC. 1995. Alterations in striatal dopamine release and reuptake under conditions of mild, moderate, and severe cerebral ischemia. Neurosurgery 37: 948-954.
103. Kotecha SA, Oak JN, Jackson MF, Perez Y, Orser BA, Van Tol HH, MacDonald JF. 2002. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 35:1111-1122.
104. Land JM, Goulder P, Johnson A, Hockaday J. 1992. Glutaric aciduria type 1 an atypical presentation together with some observations upon treatment and the possible cause of cerebral damage. Neuropediatrics 23: 322-326.
105. Landis DMD. 1994. The early reactions of non-neuronal cells to brain injury. Annu Rev Neurosci 17:133-151.
106. Largo C, Cuevas P, Herreras O. 1996a. Is glia disfunction the initial cause of neuronal death in ischemic penumbra? Neurol Res 18:445-448.
107. Largo C, Cuevas P. Somjen GG, Martin del Rio R, Herreras O. 1996b. The effect of depressing glial function in rat brain in situ on ion homeostasis, synaptic transmission, and neuron survival. J Neurosci 16:1219-1229.
108. Largo C, Ibarz JM, Herreras O. 1997. Effects of the gliotoxin fluorocitrate on spreading depression and glial membrane potential in rat brain in situ. J Neurophysiol 78:295-307.
109. Larsen PD, Crisp D. 1996. Acute bilateral striatal necrosis associated with Mycoplasma pneumoniae infection. Pediatr Infect Dis J 15: 1124-1126.
110. Lee YW, Hennig B, Yao J, Toborek M. 2001. Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J Neurosci Res 66:583-591.
111. Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M. 1991. 3-Nitropropionic acid - exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18: 492-498.
112. Magistretti PJ. 1999. Brain energy metabolism. In: Zigmond MJ, Bloom FE, Landis SC, Roberts JL, Squire LR, editors. Fundamental neuroscience. San Diego: Academic Press. p 389-416.
113. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. 1999. Energy on demand. Science 283:496-497.
114. Manos P, Bryan GK. 1993. Cellular and subcellular compartmentation of creatine kinase in brain. Dev Neurosci 15:271-279.
115. Maragos WF, Zhu J, Chesnut MD, Dwoskin LP. 2002. Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes. Biochem Pharmacol 63: 1499-1505.
116. Marie C, Mossiat C, Beley A, Bralet J. 1992. Alpha-methyl-para-tyrosine pretreatment protects from striatal neuronal death induced by four-vessel occlusion in the rat. Neurochem Res 17:961-965.
117. Marinkovic S, Gibo H, Milisavljevic M, Cetkovic M. 2001. Anatomic and clinical correlations of the lenticulostriate arteries. Clin Anat 14:190-195.
118. Mark KS, Davis TP. 2002. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 282:H1485-H1494.
119. Martin LJ, Brambrink AM, Lehmann C, Portera-Cailliau C, Koehler Rothstein J, Traystman RJ. 1997. Hypoxia-ischemia causes abnormalities in glutamate transport and death of astroglia and neurons in newborn striatum. Ann Neurol 43:335-348.
120. Massieu L, Del Rio P, Montiel T. 2001. Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates. Neuroscience 106:669-677.
121. Mayhan WG. 1996. Role of nitric oxide in histamine-induced increases in permeability of the blood-brain barrier. Brain Res 743: 70-76.
122. Mayhan WG. 2001. Regulation of blood-brain barrier permeability. Microcirculation 8: 89-104.
123. Meada K, Haca R, Hossmann KA. 1999. Regional metabolic disturbances and cerebrovasculaar anatomy after permanent middle cerebral artery occlusion in C57Black/6 and SV129 mice. Neurobiol Dis 6:101-108.
124. Mrsulja BB, Ueki Y, Lust WD. 1986. Regional metabolite profiles in early stages of global ischemia in the gerbil. Metab Brain Dis 1: 205-220.
125. Mrsulja BB, Ueki Y, Lust WD. 1988. Delayed hypometabolism induced by bilateral ischemia in the gerbil: regional metabolic thresholds. Metab Brain Dis 3:279-285.
126. Muramatsu K, Fukuda A, Togari H, Wada Y, Nishino H. 1997. Vulnerability to cerebral hypoxic-ischemic insult in neonatal but not in adult rats is in parallel with disruption of the blood-brain barrier. Stroke 28:2281-2289.
127. Muruganandam A, Smith C, Ball R, Herring T, Stanimirovic D. 2000. Glutathione homeostasis and leukotriene-induced permeability in human blood-brain barrier endothelial cells subjected to in vitro ischemia. Acta Neurochir Suppl 76:29-34.
128. Nakane H, Ooboshi H, Ibayashi S, Yao H, Sadoshima S, Fujishima M. 1995. Isradipine, a calcium channel blocker, attenuates the ischemia-induced release of dopamine but not glutamate in rats. Neurosci Lett 188: 151-154.
129. Nishino H, Czurko A, Fukuda A, Hashitani T, Hida H, Karadi Z, Lenard L. 1994. Pathophysiological process after transient ischemia of the middle cerebral artery in the rat. Brain Res Bull 35:51-56.
130. Nishino H, Shimano Y, Kumazaki M, Sakurai T. 1995a. Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood-brain barrier. Neurosci Lett 186:161-164.
131. Nishino H, Shimano Y, Kumazaki M, Sakurai T, Hida H, Fujimoto I, Fukuda A. 1995b. Hypothalamic neurons are resistant to the intoxication with 3-nitropropionic acid that induces lesions in the striatum and hippocampus via the damage in the blood-brain barrier. Neurobiology (Bp) 3:257-267.
132. Nishino H, Fujimoto I, Shimano Y, Hida H, Kumazaki M, Fukuda A. 1996. 3-Nitropropionic acid produces striatum selective lesions accompanied by iNOS expression. J Chem Neuroanat 10:209-212.
133. Nishino H, Kumazaki M, Fukuda A, Fujimoto I, Shimano Y, Hida H, Sakurai T, Deshpande SB, Shimizu H, Morikawa S, Inubushi T. 1997. Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity. Neurosci Res 27:343-355.
134. Nishino H, Hida H, Kumazaki M, Shimano Y, Nakajima K, Shimizu H, Ooiwa T, Baba H. 2000. The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability. J Neurotrauma 17: 231-260.
135. Nowicki JP, Assumel-Lurdin C, Duverger D, MacKenzie ET. 1988. Temporal evolution of regional energy metabolism following focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 8:462-473.
136. Okun JG, Horster F, Farkas LM, Feyh P, Hinz A, Sauer S, Hoffmann GF, Unsicker K, Mayatepek E, Kolker S. 2002. Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277: 14674-14680.
137. Olney JW, Ishimaru MJ. 1999. Excitotoxic cell death. In: Koliatsos VE, Ratan RR, editors. Cell death and diseases of the nervous system. Totawa, NJ: Humana Press. p 197-220.
138. Ouary S, Bizat N, Altairac S, Menetrat H, Mirtoux V, Conde F, Hantraye P, Brouillet E. 2000. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Neuroscience 97:521-530.
139. Pahan K, Sheikh FG, Namboodiri AM, Singh I. 1998. N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic Biol Med 24:39-48.
140. Pang ZP, Ling GY, Gajenditan M, Xu ZC. 2002. Asymmetrical changes of excitatory synaptic transmission in dopamine-denervated striatum after transient forebrain ischemia. Neuroscience 114:317-326.
141. Panula P, Karlstedt K, Sallmen T, Peitsar N, Kaslin J, Michelsen KA, Anichtchik O, Kukko-Lukjanov T, Lintunen M. 2000. The histaminergic system in the brain: structural characteristics and changes in hibernation. J Chem Neuroanat 18:65-74.
142. Patnaik R, Mohanty S, Sharma HS. 2000. Blockade of histamine H2 receptors attenuate blood-brain barrier permeability, cerebral blood flow disturbances, edema formation and cell reactions following hyperthermic brain injury in the rat. Acta Neurochir Suppl 76:535-539.
143. Perez-Otano I, McMillian MK, Chen J, Bing G, Hong JS, Pennypacker KR. 1996. Induction of NFkB-like transcription factors in brain areas susceptible to kainate toxicity. Glia 16: 306-315.
144. Pluta R, Lossinsky AS, Wisniewski HM, Mossakowski MJ. 1994. Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest. Brain Res 633:41-52.
145. Rabinovic AD, Lewis DA, Hastings TG. 2000. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine. Neuroscience 101:67-76.
146. Reiter RJ, Tan DX, Qi W, Manchester LC, Karbownik M, Calvo JR. 2000. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Signals Recept 9:160-171.
147. Reynolds DS, Carter RJ, Morton AJ. 1998. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J Neurosci 18:10116-10127.
148. Rieke GK, Bowers DE Jr, Penn P. 1981. Vascular supply pattern to rat caudatoputamen and globus pallidus: scanning electronmicroscopic study of vascular endocasts of stroke-prone vessels. Stroke 12:840-847.
149. Ritter LS, Orozco JA, Coull BM, McDonagh PF, Rosenblum WI. 2000. Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke. Stroke 31:1153-1161.
150. Rossi DJ, Oshima T, Attwell D. 2000. Glutamate release in severe brain ischemia is mainly by reversed uptake. Nature 403:316-321.
151. Sarker MH, Fraser PA. 2002. The role of guanylyl cyclases in the permeability response to inflammatory mediators in pial venular capillaries in the rat. J Physiol 540(Pt 1): 209-218.
152. Saulle E, Centonze D, Martin AB, Moratalla R, Bernardi G, Calabresi P. 2002. Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors. Stroke 33: 2978-2984.
153. Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipollini PB, Mecocci P, Kowall NW, Rosen Br, Beal MF. 1995. Blockade of neuronal nitric oxide protects against excitotoxicity in vivo. J Neurosci 15:8419-8429.
154. Schulz JB, Henshaw DR, MacGarvey U, Beal MF. 1996. Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochem Int 29:167-171.
155. Schulz JB, Lindenau J, Seyfried J, Dichgans J. 2000. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267: 8419-4911.
156. Seeman P. 1987. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1:133-152.
157. Shefer-Kaufman N, Mimouni FB, Stavorovsky Z, Meyer JJ, Dollberg S. 1999. Incidence and clinical significance of echogenic vasculature in the basal ganglia of newborns. Am J Perinatol 16:315-319.
158. Shibata M, Kumar SR, Amar A, Fernandez JA, Hofman F, Griffin JH, Zlokovic BV. 2001. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 103:1799-1805.
159. Shigeno T, McCulloch J, Graham DI, Mendelow AD, Teasdale GM. 1985. Pure cortical ischemia versus striatal ischemia. Circulatory, metabolic, and neuropathologic consequences. Surg Neurol 24:47-51.
160. Shinawi M, Gruener N, Lerner A. 1998. CSF levels of carnitine in children with meningitis, neurologic disorders, acute gastroenteritis, and seizure. Neurology 50:1869-1871.
161. Shukla A, Dikshit M, Srimal RC. 1995. Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium. Neuroreport 6:1629-1632.
162. Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG. 1998. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci USA 95:316-321.
163. Soto-Otero R, Mendez-Alvarez E, Hermida-Ameijeiras A, Munoz-Patino AM, Labandeira-Garcia JL. 2000. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem 74: 1605-1612.
164. Stachowiak O, Dolder M, Wallimann T, Richter C. 1998. Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. J Biol Chem 273:16694-16699.
165. Standaert DG, Young AB. 2001. Treatment of central nervous system degenerative disorders. In: Hardman JG, Limbird LE, editors. The pharmacological basis of therapeutics, 10th edition. New York: McGraw-Hill. p 549-568.
166. Ste-Marie L, Vachon P, Vachon L, Bemeur C, Guertin MC, Montgomery J. 2000. Hydroxyl radical production in the cortex and striatum in a rat model of focal cerebral ischemia. Can J Neurol Sci 27:152-159.
167. Sternberg EM, Young WS 3rd, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL. 1989. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 86:4771-4775.
168. Sternberg EM, Glowa JR, Smith MA, Calogero AE, Listwak SJ, Aksentijevich S, Chrousos GP, Wilder RL, Gold PW. 1992. Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res 570:54-60.
169. Strauss KA, Puffenberger EG, Robinson DL, Morton DH. 2003a. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet (Sem Med Genet) 121C:38-52.
170. Strauss KA, Pfannl R, Morton DH. 2003b. The neuropathology of Amisle lethal microcephaly. Am J Hum Genet 71(Suppl 4):28.
171. Sugiyama N, Kidouchi K, Kobayashi M, Wada Y. 1990. Carnitine deficiency in inherited organic acid disorders and Reye syndrome. Acta Paediatr Jpn 32:410-416.
172. Sun Z, Xie J, Reiner A. 2002. The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease. Exp Neurol 176:55-65.
173. Tam DA, Leschner RT. 1995. Stroke in purine nucleoside phosphorylase deficiency. Pediatr Neurol 12:146-148.
174. Tarnopolsky MA, Beal MF. 2001. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol 49:561-574.
175. Teunissen CE, Markerink-van Ittersum M, de Bruijn C, Steinbusch HW, de Vente J. 2002. Evaluation of 3-nitrotyrosine as a marker for 3-nitropropionic acid-induced oxidative stress in Lewis and Wistar rats and strain-specific whole brain spheroid cultures. Brain Res 931:5-20.
176. Thiel VE, Audus KL. 2001. Nitric oxide and blood-brain barrier integrity. Antioxid Redox Signal 3:273-278.
177. Thorngren-Jerneck K, Ley D, Hellstrom-Westas L, Hernandez-Andrade E, Lingman G, Ohlsson T, Oskarsson G, Pesonen E, Sandell A, Strand SE, Werner O, Marsal K. 2001. Reduced postnatal cerebral glucose metabolism measured by PET after asphyxia in near term fetal lambs. J Neurosci Res 66:844-850.
178. Tomkins O, Kaufer D, Korn A, Shelef I, Golan H, Reichenthal E, Soreq H, Friedman A. 2001. Frequent blood-brain barrier disruption in the human cerebral cortex. Cell Mol Neurobiol 21:675-691.
179. Toner CC, Stamford JA. 1996. 'Real time' measurement of dopamine release in an in vitro model of neostriatal ischaemia. J Neurosci Methods 67:133-140.
180. Toner CC, Stamford JA. 1997. Sodium channel blockade unmasks two temporally distinct mechanisms of striatal dopamine release during hypoxia/hypoglycaemia in vitro. Neuroscience 81:999-1007.
181. Toner CC, Stamford JA. 1999. Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia. Brain Res Bull 48:395-399.
182. Tsao N, Hsu HP, Wu CM, Liu CC, Lei HY. 2001. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol 50:812-821.
183. Tsuji A, Tamai I. 1998. Blood-brain barrier transport of drugs. In: Pardridge WM, editor. Introduction to the blood-brain barrier. Cambridge, U.K.: Cambridge University Press. p 238-247.
184. Ullrich K, Flott-Rahmel B, Schluff P, Musshoff U, Das A, Lucke T, Steinfeld R, Christensen E, Jakobs C, Ludolph A, Neu A, Roper R. 1999. Glutaric aciduria type I: pathomechanisms of neurodegeneration. J Inherit Metab Dis 22:392-403.
185. Van de Kar LD, Blair ML. 1999. Forebrain pathways mediating stress-induced hormone secretion. Front Neuroendocrinol 20:1-48.
186. Van der Ent CK, de Vroede MA, Augustijn PB, Wit JM. 1995. A special case of congenital adrenal hypoplasia and acute bilateral infantile striatal necrosis. Acta Paediatr 84:957-960.
187. Vannucci RC, Yager JY. 1998. Perinatal brain metabolism. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology, 2nd edition. Philadelphia: W.B. Saunders Company p 2123-2137.
188. Volpe JJ. 2001. Hypoxic-ischemic encephalopathy: biochemical and physiological aspects. In: Neurology of the newborn, 4th edition. Philadelphia: W.B. Saunders Company. p 217-277.
189. von Essen C, Zervas NT, Brown DR, Koltun WA, Pickren KS. 1980. Local cerebral blood flow in the dog during intravenous infusion of dopamine. Surg Neurol 13:181-188.
190. Vornov JJ. 1999. Blood flow, energy failure, and vulnerability to stroke. In: Koliatsos VE, Ratan RR, editors. Cell death and diseases of the nervous system. Totawa, NJ: Humana Press. p 343-360.
191. Wallace DC, Lott MT, Brown MD, Kerstann K. 2001. Mitochondria and neuro-ophthalmological diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, editors. The metabolic and molecular bases of inherited disease, 8th edition. New York: McGraw-Hill. p 2425-2512.
192. Wallimann T, Hemmer W. 1994. Creatine kinase in non-muscle tissues and cells. Mol Cell Biochem 133(134):193-220.
193. Wallimann T, Dolder M, Schlattner U, Eder M, Hornemann T, O'Gorman E, Ruck A, Brdiczka D. 1998. Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. Biofactors 8:229-234.
194. Wang J, Yang X, Camporesi CV, Yang Z, Bosco G, Chen C, Camporesi EM. 2002. Propofol reduces infarct size and striatal dopamine accumulation following transient middle cerebral artery occlusion: a microdialysis study. Eur J Pharmacol 452:303-308.
195. White RP, Hagen A, Robertson JT. 1976. Experimental evaluation of the spasmogenicity of dopamine on the basilar artery. J Neurosurg 44:45-49.
196. Wisniewski HM, Lossinsky AS. 1998. Microvascular pathology in cerebrovascular ischemia. In: Pardridge WM, editor. Introduction to the blood-brain barrier. Cambridge, U.K.: Cambridge University Press, p 409-418.
197. Wolfram-Gabel R, Maillot C. 1994. Vascular networks of the nucleus lentiformis. Surg Radiol Anat 16:373-377.
198. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD Jr, DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW. 2000. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 97:325-330.
199. Yamamoto K, Chiba HO, Ishitobi M, Nakagawa H, Ogawa T, Ishii K. 1997. Acute encephalopathy with bilateral striatal necrosis: favourable response to corticosteroid therapy. Eur J Paediatr Neurol 1:41-45.
200. Younkin DP. 1998. Physiologic aspects of nuclear magnetic resonance spectroscopy. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology, 2nd edition. Philadelphia: W.B. Saunders Company. p 2137-2146.
201. Zelazowski P, Smith MA, Gold PW, Chrousos GP, Wilder RL, Sternberg EM. 1992. In vitro regulation of pituitary ACTH secretion in inflammatory disease susceptible Lewis (LEW/N) and inflammatory disease resistant Fischer (F344/N) rats. Neuroendocrinology 56:474-482.
202. Zhang W, Smith C, Howlett C, Stanimirovic D. 2000. Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1b. J Cereb Blood Flow Metab 20:967-978.